CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, has entered into a long-term loan and security agreement with Hercules Technology Growth Capital, Inc. and Hercules Technology III, L.P. for up to $40...
Read Story
February 09, 2016, 07:27 AM
|
ReWalk Robotics Ltd. has entered into an agreement with Kreos Capital V (Expert Fund) Limited for a line of credit of up to $20 million. ReWalk drew down an initial tranche of $12 million. An additional $8 million dollars will be available in...
Read Story
January 04, 2016, 07:40 AM
|
Avinger, Inc., a developer and manufacturer of image-guided, catheter-based systems for the treatment of peripheral arterial disease (PAD) and pioneer of the lumivascular approach to treating vascular disease, has entered into a term loan agreement...
Read Story
September 23, 2015, 07:16 AM
|
Ocera Therapeutics secured a $20 million debt facility from Oxford Finance and Silicon Valley Bank (SVB). Ocera intends to use the additional capital to support the ongoing development of the company's novel molecule OCR-002 to treat acute and...
Read Story
July 31, 2015, 07:31 AM
|
Agile Therapeutics, Inc., a women's health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products, announced that it has entered into a loan and security agreement with Hercules...
Read Story
February 25, 2015, 07:10 AM
|
CareDx, Inc., a molecular diagnostics company focused on the development and commercialization of clinically differentiated, high value, non-invasive surveillance solutions for transplant recipients, today announced that it has entered into a secured...
Read Story
February 04, 2015, 07:33 AM
|
CAS Medical Systems, Inc., a leader in medical devices for non-invasive patient monitoring, announced that on Friday, June 27, 2014, the Company entered into a Loan and Security Agreement (the "Loan Agreement") with General Electric Capital...
Read Story
July 01, 2014, 07:19 AM
|
Ceterix Orthopaedics, Inc., a developer of novel surgical tools for arthroscopic procedures, announced that the company has closed $18 million in new financing. Previous investors Novo A/S, Versant Ventures and 5AM Ventures participated in the round...
Read Story
May 14, 2014, 07:04 AM
|